Nantahala Capital Management
NEW CANAAN, CTfiles as Nantahala Capital Management, LLC
$3.3bn in 131 US stocks at the end of 30 June 2026. The top 10 are 27.6% of the money. It changed about 19.4% of the portfolio this quarter.
Value
$3.3bn
Stocks
131
Top 10 share
27.6%
Turnover
19.4%
What changed this quarter
New
Bought for the first time this quarter.
- Adma BiologicsADMA1.2% of the fund
- Vor BiopharmaVOR0.9% of the fund
- Planet FitnessPLNT0.9% of the fund
- Amanat AcquisitionAMAN0.7% of the fund
- Inspire Medical SystemsINSP0.7% of the fund
- InventivaIVA0.6% of the fund
- Perspective TherapeuticsCATX0.5% of the fund
- Irenic AcquisitionIACQU0.5% of the fund
- Eloxx PharmaceuticalsELOX0.3% of the fund
- First Tracks BiotherapeuticsTRAX0.3% of the fund
- AltimmuneALT0.3% of the fund
- ImmunicIMUX0.2% of the fund
- ZAI LABZLAB0.2% of the fund
- Kailera TherapeuticsKLRA0.2% of the fund
- Artiva BiotherapeuticsARTV0.2% of the fund
- Editas MedicineEDIT0.2% of the fund
- JATT II AcquisitionJATT0.2% of the fund
- ALX Oncology HoldingsALXO<0.1% of the fund
- SnapSNAP<0.1% of the fund
- Cellectar BiosciencesCLRB<0.1% of the fund
- Senti Biosciences HoldingsSNTI<0.1% of the fund
- AzitraAZTR<0.1% of the fund
Added
Bought more of a stock they already held.
- BancorpTBBK4.7% of the fund+80%
- BioventusBVS3.4% of the fund+96%
- Hilton Grand VacationsHGV3.3% of the fund+37%
- SavaraSVRA2.6% of the fund+90%
- Eton PharmaceuticalsETON2.6% of the fund+100%
- Amneal PharmaceuticalsAMRX2.4% of the fund+60%
- EvolusEOLS2.4% of the fund+76%
- Avalo TherapeuticsAVTX2.1% of the fund+202%
- LB PharmaceuticalsLBRX2.1% of the fund+100%
- Anteris Technologies GlobalAVR2.0% of the fund+22%
- Abeona TherapeuticsABEO1.9% of the fund+105%
- Xtant Medical HoldingsXTNT1.8% of the fund+100%
- Jack IN the BOXJACK1.7% of the fund+124%
- GogoGOGO1.6% of the fund+96%
- ImaxIMAX1.6% of the fund+155%
- Zevra TherapeuticsZVRA1.6% of the fund+43%
- Titan MachineryTITN1.5% of the fund+81%
- RMR GroupRMR1.4% of the fund+100%
- Fossil GroupFOSL1.4% of the fund+104%
- Fox Factory HoldingFOXF1.4% of the fund+76%
- Mineralys TherapeuticsMLYS1.3% of the fund+83%
- RideNow GroupRDNW1.3% of the fund+100%
- uniQureQURE1.3% of the fund+284%
- Aura BiosciencesAURA1.3% of the fund+179%
- AgomAb Therapeutics NVAGMB1.2% of the fund+161%
Cut
Sold some of their stake.
- Peloton InteractivePTON1.8% of the fund-15%
- Establishment Labs HoldingsESTA1.8% of the fund-19%
- Tango TherapeuticsTNGX1.0% of the fund-20%
- TriSalus Life SciencesTLSI0.3% of the fund-3%
- Service Properties TrustSVC0.3% of the fund-25%
- BRCBRCC<0.1% of the fund-4%
Sold out
Sold their entire stake.
- Soleno Therapeutics-100%
- Assertio Holdings-100%
- Centessa Pharmaceuticals-100%
- Cogent BiosciencesCOGT-100%
- Solid BiosciencesSLDB-100%
- Dianthus TherapeuticsDNTH-100%
- Kosmos EnergyKOS-100%
- Revolution MedicinesRVMD-100%
- Caesars EntertainmentCZR-100%
- Upstream BioUPB-100%
- NNNNBR-100%
- Grace TherapeuticsGRCE-100%
- CG OncologyCGON-100%
- XencorXNCR-100%
- ImmunicIMUX-100%
- Achieve Life SciencesACHV-100%
- Disc MedicineIRON-100%
- PepGenPEPG-100%
- Senti Biosciences-100%
- PerfectPERFF-100%
Holdings
- Abivax SAABVX
- Share
- 1.1%
- Value
- $36m
- Shares
- 267,518
+95%
- Helix Acquisition Corp. IIIHLXC
- Share
- 0.8%
- Value
- $27m
- Shares
- 2,500,000
+100%
- Amanat AcquisitionAMAN
- Share
- 0.7%
- Value
- $24m
- Shares
- 2,400,000
New
- Irenic AcquisitionIACQU
- Share
- 0.5%
- Value
- $15m
- Shares
- 1,500,000
New
- Damora Therapeutics
- Share
- 0.4%
- Value
- $14m
- Shares
- 556,000
+100%
- First Tracks BiotherapeuticsTRAX
- Share
- 0.3%
- Value
- $10m
- Shares
- 500,000
New
- ZAI LABZLAB
- Share
- 0.2%
- Value
- $8m
- Shares
- 400,000
New
- Kailera TherapeuticsKLRA
- Share
- 0.2%
- Value
- $6m
- Shares
- 280,000
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| BancorpTBBK | 4.7% | $155m | 2,479,774 | +80% |
| BioventusBVS | 3.4% | $113m | 12,000,558 | +96% |
| Hilton Grand VacationsHGV | 3.3% | $108m | 2,066,340 | +37% |
| SavaraSVRA | 2.6% | $86m | 13,953,620 | +90% |
| Eton PharmaceuticalsETON | 2.6% | $85m | 2,351,902 | +100% |
| Amneal PharmaceuticalsAMRX | 2.4% | $79m | 4,537,502 | +60% |
| EvolusEOLS | 2.4% | $78m | 11,204,042 | +76% |
| Avalo TherapeuticsAVTX | 2.1% | $69m | 3,724,500 | +202% |
| LB PharmaceuticalsLBRX | 2.1% | $68m | 2,105,788 | +100% |
| Anteris Technologies GlobalAVR | 2.0% | $67m | 6,766,670 | +22% |
| Abeona TherapeuticsABEO | 1.9% | $63m | 10,272,980 | +105% |
| Peloton InteractivePTON | 1.8% | $60m | 10,217,990 | -15% |
| Establishment Labs HoldingsESTA | 1.8% | $58m | 671,660 | -19% |
| Xtant Medical HoldingsXTNT | 1.8% | $58m | 136,788,000 | +100% |
| Jack IN the BOXJACK | 1.7% | $55m | 3,457,318 | +124% |
| GogoGOGO | 1.6% | $54m | 17,395,462 | +96% |
| ImaxIMAX | 1.6% | $52m | 1,316,018 | +155% |
| Zevra TherapeuticsZVRA | 1.6% | $52m | 3,594,952 | +43% |
| Titan MachineryTITN | 1.5% | $48m | 2,266,176 | +81% |
| RMR GroupRMR | 1.4% | $47m | 2,295,804 | +100% |
| Fossil GroupFOSL | 1.4% | $46m | 11,010,256 | +104% |
| Fox Factory HoldingFOXF | 1.4% | $44m | 2,621,390 | +76% |
| Mineralys TherapeuticsMLYS | 1.3% | $44m | 1,640,962 | +83% |
| RideNow GroupRDNW | 1.3% | $44m | 6,545,690 | +100% |
| uniQureQURE | 1.3% | $42m | 911,320 | +284% |
| Aura BiosciencesAURA | 1.3% | $42m | 5,902,060 | +179% |
| AgomAb Therapeutics NVAGMB | 1.2% | $41m | 3,136,376 | +161% |
| Fulcrum TherapeuticsFULC | 1.2% | $40m | 10,950,080 | +259% |
| Benitec BiopharmaBNTC | 1.2% | $40m | 2,976,742 | +107% |
| Adma BiologicsADMA | 1.2% | $40m | 4,719,986 | New |
| Camping World HoldingsCWH | 1.2% | $39m | 5,102,110 | +57% |
| Biocryst PharmaceuticalsBCRX | 1.2% | $38m | 3,802,320 | +91% |
| Mimedx GroupMDXG | 1.1% | $37m | 9,535,104 | +181% |
| Abivax SAABVX | 1.1% | $36m | 267,518 | +95% |
| Usana Health SciencesUSNA | 1.1% | $35m | 1,620,148 | +100% |
| Monte Rosa TherapeuticsGLUE | 1.0% | $32m | 1,303,986 | +100% |
| Tango TherapeuticsTNGX | 1.0% | $31m | 1,001,318 | -20% |
| GeronGERN | 1.0% | $31m | 24,450,000 | +118% |
| Vor BiopharmaVOR | 0.9% | $31m | 1,690,000 | New |
| Keros TherapeuticsKROS | 0.9% | $30m | 2,820,838 | +107% |
| Silence TherapeuticsSLN | 0.9% | $30m | 2,693,462 | +25% |
| Apyx MedicalAPYX | 0.9% | $29m | 6,540,496 | +90% |
| Jefferson CapitalJCAP | 0.9% | $29m | 1,500,000 | +100% |
| HerbalifeHLF | 0.9% | $29m | 2,218,308 | +64% |
| Planet FitnessPLNT | 0.9% | $29m | 558,000 | New |
| VerastemVSTM | 0.8% | $27m | 7,169,640 | +100% |
| Distribution Solutions GroupDSGR | 0.8% | $27m | 989,162 | +100% |
| Rayonier Advanced MaterialsRYAM | 0.8% | $27m | 3,395,452 | +112% |
| Helix Acquisition Corp. IIIHLXC | 0.8% | $27m | 2,500,000 | +100% |
| ADC Therapeutics SAADCT | 0.8% | $26m | 24,652,368 | +340% |
| VaxcytePCVX | 0.8% | $26m | 444,292 | +86% |
| Opus GeneticsIRD | 0.8% | $25m | 6,122,718 | +264% |
| Janux TherapeuticsJANX | 0.8% | $25m | 1,619,828 | +100% |
| Amanat AcquisitionAMAN | 0.7% | $24m | 2,400,000 | New |
| Inspire Medical SystemsINSP | 0.7% | $24m | 538,948 | New |
| 1-800-Flowers.comFLWS | 0.7% | $23m | 6,750,130 | +100% |
| X4 PharmaceuticalsXFOR | 0.7% | $23m | 4,898,936 | +100% |
| Integer HoldingsITGR | 0.6% | $21m | 222,604 | +29% |
| InventivaIVA | 0.6% | $20m | 5,372,786 | New |
| Industrial Logistics Properties TrustILPT | 0.6% | $20m | 2,222,306 | +32% |
| DuolingoDUOL | 0.6% | $19m | 167,754 | +68% |
| Reservoir MediaRSVR | 0.6% | $19m | 1,881,920 | +100% |
| Fractyl HealthGUTS | 0.5% | $18m | 22,578,192 | +69% |
| DHI GroupDHX | 0.5% | $18m | 4,748,054 | +100% |
| Amylyx PharmaceuticalsAMLX | 0.5% | $17m | 973,368 | +82% |
| Korro BioKRRO | 0.5% | $17m | 1,320,072 | +100% |
| AlectorALEC | 0.5% | $17m | 8,636,218 | +207% |
| NoodlesNDLS | 0.5% | $17m | 1,107,492 | +100% |
| CodexisCDXS | 0.5% | $16m | 7,247,226 | +76% |
| Perspective TherapeuticsCATX | 0.5% | $16m | 4,650,900 | New |
| Irenic AcquisitionIACQU | 0.5% | $15m | 1,500,000 | New |
| Damora Therapeutics | 0.4% | $14m | 556,000 | +100% |
| Viemed HealthcareVMD | 0.4% | $14m | 1,264,890 | +43% |
| Unicycive TherapeuticsUNCY | 0.4% | $13m | 2,802,894 | +198% |
| TraegerCOOK | 0.4% | $13m | 165,662 | +62% |
| Forrester ResearchFORR | 0.4% | $13m | 1,526,892 | +120% |
| Lexeo TherapeuticsLXEO | 0.4% | $12m | 2,600,000 | +117% |
| RHRH | 0.4% | $12m | 73,372 | +27% |
| Envoy MedicalCOCH | 0.4% | $12m | 15,300,000 | +100% |
| Eloxx PharmaceuticalsELOX | 0.3% | $11m | 800,000 | New |
| Inhibikase TherapeuticsIKT | 0.3% | $11m | 5,403,726 | +100% |
| First Tracks BiotherapeuticsTRAX | 0.3% | $10m | 500,000 | New |
| Hain Celestial GroupHAIN | 0.3% | $10m | 17,057,578 | +100% |
| Alta Equipment GroupALTG | 0.3% | $9m | 1,449,548 | +55% |
| OrthopediatricsKIDS | 0.3% | $9m | 484,684 | +143% |
| AltimmuneALT | 0.3% | $9m | 3,000,000 | New |
| TriSalus Life SciencesTLSI | 0.3% | $9m | 2,000,000 | -3% |
| Service Properties TrustSVC | 0.3% | $9m | 5,322,641 | -25% |
| TELA BioTELA | 0.3% | $9m | 11,788,228 | +129% |
| ONE Group HospitalitySTKS | 0.3% | $9m | 4,242,168 | +100% |
| DarioHealthDRIO | 0.2% | $8m | 1,221,382 | +100% |
| ImmunicIMUX | 0.2% | $8m | 501,292 | New |
| ZAI LABZLAB | 0.2% | $8m | 400,000 | New |
| TalpheraTLPH | 0.2% | $7m | 6,985,038 | +100% |
| Chime FinancialCHYM | 0.2% | $7m | 344,238 | +72% |
| Venu HoldingVENU | 0.2% | $7m | 3,093,410 | +51% |
| Payoneer GlobalPAYO | 0.2% | $7m | 967,672 | +100% |
| ElutiaELUT | 0.2% | $6m | 6,369,894 | +100% |
| Kailera TherapeuticsKLRA | 0.2% | $6m | 280,000 | New |
| RallybioRLYB | 0.2% | $6m | 376,844 | +25% |
Showing the largest 100 of 131.
Options (23)
- Ishares TRIWM
- Type
- Put
- Value
- $1.2bn
- Contracts
- 4,000,000
- Peloton InteractivePTON
- Type
- Call
- Value
- $194m
- Contracts
- 32,877,800
- HerbalifeHLF
- Type
- Call
- Value
- $174m
- Contracts
- 13,200,000
- ViatrisVTRS
- Type
- Call
- Value
- $159m
- Contracts
- 10,000,000
- Edwards LifesciencesEW
- Type
- Put
- Value
- $145m
- Contracts
- 1,600,000
- Spdr Series TrustXBI
- Type
- Put
- Value
- $127m
- Contracts
- 800,000
- Hilton Grand VacationsHGV
- Type
- Call
- Value
- $113m
- Contracts
- 2,150,000
- ETF SER SolutionsQTUM
- Type
- Put
- Value
- $74m
- Contracts
- 446,000
- uniQureQURE
- Type
- Call
- Value
- $74m
- Contracts
- 1,600,000
- Neurocrine BiosciencesNBIX
- Type
- Call
- Value
- $67m
- Contracts
- 400,000
- Praxis Precision MedicinesPRAX
- Type
- Put
- Value
- $67m
- Contracts
- 200,000
- Krystal BiotechKRYS
- Type
- Put
- Value
- $63m
- Contracts
- 170,000
- Regeneron PharmaceuticalsREGN
- Type
- Call
- Value
- $50m
- Contracts
- 80,000
- SnapSNAP
- Type
- Call
- Value
- $43m
- Contracts
- 9,600,000
- Camping World HoldingsCWH
- Type
- Call
- Value
- $31m
- Contracts
- 4,000,000
- Fox Factory HoldingFOXF
- Type
- Call
- Value
- $27m
- Contracts
- 1,600,000
- Chime FinancialCHYM
- Type
- Call
- Value
- $25m
- Contracts
- 1,200,000
- RideNow GroupRDNW
- Type
- Call
- Value
- $23m
- Contracts
- 3,400,000
- RHRH
- Type
- Call
- Value
- $16m
- Contracts
- 100,000
- BancorpTBBK
- Type
- Call
- Value
- $16m
- Contracts
- 251,600
- uniQureQURE
- Type
- Put
- Value
- $15m
- Contracts
- 323,000
- Abeona TherapeuticsABEO
- Type
- Call
- Value
- $13m
- Contracts
- 2,040,000
- VaxcytePCVX
- Type
- Call
- Value
- $4m
- Contracts
- 70,400
| Company | Type | Value | Contracts |
|---|---|---|---|
| Ishares TRIWM | Put | $1.2bn | 4,000,000 |
| Peloton InteractivePTON | Call | $194m | 32,877,800 |
| HerbalifeHLF | Call | $174m | 13,200,000 |
| ViatrisVTRS | Call | $159m | 10,000,000 |
| Edwards LifesciencesEW | Put | $145m | 1,600,000 |
| Spdr Series TrustXBI | Put | $127m | 800,000 |
| Hilton Grand VacationsHGV | Call | $113m | 2,150,000 |
| ETF SER SolutionsQTUM | Put | $74m | 446,000 |
| uniQureQURE | Call | $74m | 1,600,000 |
| Neurocrine BiosciencesNBIX | Call | $67m | 400,000 |
| Praxis Precision MedicinesPRAX | Put | $67m | 200,000 |
| Krystal BiotechKRYS | Put | $63m | 170,000 |
| Regeneron PharmaceuticalsREGN | Call | $50m | 80,000 |
| SnapSNAP | Call | $43m | 9,600,000 |
| Camping World HoldingsCWH | Call | $31m | 4,000,000 |
| Fox Factory HoldingFOXF | Call | $27m | 1,600,000 |
| Chime FinancialCHYM | Call | $25m | 1,200,000 |
| RideNow GroupRDNW | Call | $23m | 3,400,000 |
| RHRH | Call | $16m | 100,000 |
| BancorpTBBK | Call | $16m | 251,600 |
| uniQureQURE | Put | $15m | 323,000 |
| Abeona TherapeuticsABEO | Call | $13m | 2,040,000 |
| VaxcytePCVX | Call | $4m | 70,400 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 132.8% since 30 June 2025.
Where the money is
Health care61.6%
Retail & consumer15.1%
Financial services7.8%
Industrials6.0%
Technology2.6%
Media & telecom1.9%
Materials1.3%
Real estate0.9%
Everyday goods0.4%
Other2.4%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.